RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TipRanksJan 10 09:50 · Ratings

Zymeworks Says It Has Enough Cash to Operate Through H2 2027

Seeking AlphaJan 9 05:33

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) Delivered A Weaker ROE Than Its Industry

Simply Wall StJan 6 22:40

Jefferies Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $170

Futu NewsJan 3 21:32 · Ratings

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)

TipRanksJan 3 21:10 · Ratings

Executive Reshuffles: BA, EXPE, TPVG and GEO

Seeking AlphaDec 22, 2024 04:56